Transient retinal artery occlusion

H7_RETARTOCCTRANS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H34.0 Cause of death: ICD-10 — H34.0 2 out of 7 registries used, show all original rules.	77
4. Check minimum number of events None	77
5. Include endpoints None	77
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H34
Name in latin: Occlusio arteriae retinalis transitoria

NAME	H7_RETARTOCCTRANS
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H340
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H340
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Transient retinal artery occlusion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	494	232	259
Only index persons	457	219	238
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	69.25	71.14	67.63
Only index persons	68.72	70.55	67.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	39	38
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	64.91	63.60	66.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
71: Matched controls
709

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H34.0

ICD-10 Finland

Transient retinal artery occlusion

+∞

102.0

H34.2

ICD-10 Finland

Other retinal artery occlusions

+∞

18.5

H34.8

ICD-10 Finland

Other retinal vascular occlusions

+∞

18.5

H34.1

ICD-10 Finland

Central retinal artery occlusion

+∞

15.1

CKC12

NOMESCO Finland

Photocoagulation of retina

+∞

11.8

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

15.5

10.5

XCD20

NOMESCO Finland

Photoangiography of eye

+∞

9.6

XCK10

NOMESCO Finland

Photography of fundus of eye

7.8

9.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

18.9

9.5

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

101.5

8.6

AA1AD

NOMESCO Finland

CT of head and brain

4.8

8.2

109

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.9

7.0

XCK00

NOMESCO Finland

Perimetry

7.9

6.8

C10AA05

ATC

atorvastatin; oral

3.7

6.6

217

H53.1

ICD-10 Finland

Subjective visual disturbances

9.1

6.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.00

3.94

5.5

6.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

325

2.54

3.68

9.1

6.3

1.2

mmol/l

0.36

273

(3032080) INR in Blood by Coagulation assay

264

2.42

3.54

21.7

9.7

1.3

1.2

inr

0.33

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3.84

3.48

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

288

2.35

3.30

6.6

4.2

35.7

34.9

g/l

0.47

278

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

8.01

3.11

1.0

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.71

3.10

1.2

1.1

—

(4306422)

10.56

3.02

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

4.34

2.65

3.0

2.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

243

2.11

2.62

2.7

2.2

81.3

78.9

nmol/l

0.20

208

(3027945) Reticulocytes/100 erythrocytes in Blood

2.55

2.61

5.6

3.3

1.8

1.6

0.29

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.42

2.42

2.7

1.2

—

(3000991) Gas panel - Venous blood

2.63

2.38

7.1

—

(3044290) Cell count panel - Cerebral spinal fluid

4.90

2.32

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.64

2.26

1.9

2.1

0.2

g/l

0.20

(3004789) Transferrin [Mass/volume] in Serum or Plasma

106

2.20

2.16

3.4

2.2

2.3

g/l

0.30

(3000492) Spirometry study

2.66

2.15

1.6

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

323

1.95

2.11

6.8

4.0

0.0

estimate

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

5.26

2.10

2.8

1.9

172.2

203.1

—

(3023520) Reticulocytes [#/volume] in Blood

2.60

2.07

3.1

3.5

72.4

67.5

e9/l

—

(3018418) pH of Serum or Plasma

206

1.95

2.06

4.6

4.3

7.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

269

1.91

2.04

5.2

4.0

39.4

37.4

ng/l

0.04

198

(3019150) Specific gravity of Urine by Refractometry

133

2.04

1.99

7.1

4.6

1.0

kg/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

263

1.88

1.94

2.5

1.9

93.4

92.1

pmol/l

0.06

121

(3021960) Folate [Moles/volume] in Serum or Plasma

167

1.95

1.93

1.6

1.5

18.0

20.1

nmol/l

0.39

137

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

292

1.86

1.91

8.1

3.9

—

(3009261) Glucose [Presence] in Urine by Test strip

332

1.86

7.0

4.1

0.0

estimate

—

(3012516) Albumin [Mass/volume] in Urine

186

1.90

1.86

4.8

3.0

103.2

40.8

mg/l

0.37

122

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3.52

1.78

1.2

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3.52

1.78

1.2

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

138

1.95

1.78

2.0

1.8

1183.6

1301.9

nmol/l

0.19

101

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2.76

1.71

1.3

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

328

1.80

1.71

9.6

5.5

0.0

estimate

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2.97

1.69

1.9

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

441

1.87

1.65

7.3

4.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

201

1.81

1.65

5.5

3.9

20.6

6.2

mg/mmol

0.40

130

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

3.74

1.64

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

0.00

1.58

0.0

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

286

1.74

1.56

8.4

5.6

2.8

2.7

0.08

268

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3.49

1.55

2.0

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3.49

1.55

1.4

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

233

1.73

1.49

6.8

2.8

21.9

63.3

e6/l

1.04

165

(3019069) Monocytes/100 leukocytes in Blood

289

1.71

1.48

8.5

6.0

8.8

8.4

0.41

271

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

636

2.49

1.46

26.6

15.2

24.0

24.4

mg/l

0.04

513

(3022096) Basophils/100 leukocytes in Blood

281

1.70

1.44

8.6

5.5

0.8

0.7

0.70

261

(3044889) 12 lead EKG panel

461

1.79

1.43

5.4

3.9

—

(3018095) Leukocytes [#/volume] in Urine

254

1.69

1.42

8.1

3.4

16.4

82.3

e6/l

2.33

173

(42870588) Differential panel, method unspecified - Blood

200

1.72

1.41

7.7

5.0

—

(3019060) Gas panel - Arterial blood

2.21

1.41

5.5

3.9

—

(3018010) Neutrophils/100 leukocytes in Blood

292

1.68

1.40

8.6

5.6

58.9

57.5

0.35

275

(3044640) Blood type and Crossmatch panel - Blood

201

1.71

1.38

5.1

2.4

—

(3012544) pH of Venous blood

2.06

1.38

4.8

3.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

126

1.79

1.31

5.1

2.5

0.7

1.1

e6/l

—

(3002030) Lymphocytes/100 leukocytes in Blood

296

1.64

1.31

8.9

5.8

26.6

27.2

0.14

277

(3030467) Casts [#/volume] in Urine by Automated count

213

1.67

1.30

5.0

2.7

0.1

0.4

e6/l

1.83

145

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

119

1.79

1.27

5.3

2.6

3.5

3.1

e6/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.74

1.23

1.6

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.15

1.23

1.2

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

154

1.70

1.23

3.0

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

380

1.61

1.18

11.7

8.6

4.0

4.4

e9/l

0.74

332

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.11

1.16

2.9

2.6

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.06

1.12

1.9

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

257

1.58

1.12

7.7

4.2

—

(3020891) Body temperature

2.30

1.11

6.0

4.3

—

(40761511) CBC panel - Blood by Automated count

661

2.37

1.11

22.3

14.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.47

1.11

1.6

1.9

0.2

g/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

134

1.67

1.05

3.7

3.0

2.5

mmol/l

0.25

119

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2.36

1.05

1.6

1.9

1.1

1.2

g/l

—

(4010399)

1.95

1.03

1.9

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

267

1.49

0.90

7.0

2.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

222

1.49

0.86

5.1

3.1

2.4

2.3

mmol/l

0.84

194

(36304419) Bacteria [Presence] in Urine

206

1.48

0.81

5.6

2.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

197

1.48

0.81

3.2

2.7

61.5

54.0

u/l

0.74

182

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.71

0.80

4.9

3.3

—

(3002256) Pathology report gross observation

1.66

0.78

1.4

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

201

1.44

0.72

3.1

3.0

25.3

35.6

u/l

2.06

188

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.73

0.70

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1.69

0.69

1.0

1.2

—

58.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

665

1.87

0.67

30.4

18.0

81.5

80.6

umol/l

0.08

665

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.57

0.66

11.1

5.1

1.1

1.0

mmol/l

0.37

(3041096) Erythrocytes [Presence] in Urine by Automated

186

1.42

0.65

9.7

3.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

151

1.44

0.62

2.9

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.61

0.0

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.62

0.59

2.1

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

636

1.59

0.58

5.9

5.2

2.4

2.7

mmol/l

1.97

575

(3002385) Erythrocyte distribution width [Ratio]

518

1.39

0.55

33.9

18.5

14.0

13.8

0.52

508

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

593

1.47

0.55

4.9

4.2

1.3

mmol/l

0.22

536

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.54

0.54

3.5

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.54

0.53

2.2

1.5

—

(36660697) Celiac disease serology panel - Serum

1.54

0.53

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

129

1.41

0.51

1.6

1.2

0.4

1.1

u/ml

—

(3022621) pH of Urine by Test strip

1.54

0.49

3.1

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

620

1.45

0.47

5.4

4.7

6.5

6.0

mmol/l

0.63

562

(3026008) Bacteria identified in Urine by Culture

215

1.32

0.47

5.4

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.48

0.46

3.5

1.8

—

(3023368) Bacteria identified in Blood by Culture

198

1.31

0.44

5.3

4.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

199

1.30

0.42

4.7

4.4

25.9

22.7

0.46

(3022145) Colonoscopy Study observation

1.47

0.41

1.7

1.3

—

(3021589) Normoblasts [#/volume] in Blood

286

1.27

0.41

14.2

9.8

0.0

e9/l

0.74

233

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.42

0.39

1.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.39

0.35

1.2

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.39

0.35

4.8

4.2

27.7

25.1

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.33

0.31

1.4

1.5

—

(3042936) Bacteria identified in Isolate by Culture

1.33

0.30

2.5

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.36

0.30

1.7

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.26

0.28

2.6

1.8

—

(40758558) Short blood count panel - Blood

171

1.23

0.27

8.8

6.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.29

0.24

2.5

1.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.23

0.22

2.8

1.8

—

(3000330) Specific gravity of Urine by Test strip

1.20

0.22

4.6

4.4

—

(3021788) Differential panel - Synovial fluid

0.00

0.21

0.0

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.1

—

(3013512) EKG study

204

1.18

0.21

5.1

4.0

—

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

119

1.22

0.19

1.9

1.4

3.0

g/l

—

(40761536) Microorganisms panel - Urine sediment

0.73

0.17

14.4

3.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.12

0.16

3.0

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

112

1.19

0.15

3.3

1.9

—

(40768797) Stomach Pathology biopsy report

1.11

0.15

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.81

0.15

1.6

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.22

0.14

8.0

7.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

601

1.16

0.14

24.8

14.6

78.9

77.9

ml/min/173m2

0.11

491

(40768804) Tissue Pathology biopsy report

231

1.12

0.13

3.0

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

153

1.14

0.12

6.9

4.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

575

1.11

0.09

30.7

15.3

37.9

39.9

0.67

392

(3019225) pH of Specimen

1.14

0.09

14.5

4.5

—

(3000494) Fungus identified in Specimen by Culture

1.07

0.08

3.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

366

1.08

0.07

3.4

2.7

—

(3029937) Albumin [Presence] in Urine by Test strip

189

1.08

0.05

9.2

4.1

0.0

estimate

—

(3003694) ABO and Rh group [Type] in Blood

169

0.93

0.03

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

228

0.95

0.02

4.0

3.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

153

1.06

0.01

2.7

1.7

359.0

436.7

pmol/l

0.53

131

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

88.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.00

0.0

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

2.7

—

5.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

0.9

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.8

—

31.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.0

2.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.00

0.00

4.7

1.9

267.5

404.8

nmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

6.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.0

7.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

3.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_RETARTOCCTRANS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_RETARTOCCTRANS	1.193 [0.88, 1.61]	0.248
Birth year	0.994 [0.99, 1.0]	0.183

During the follow-up period (1.1.1998 — 31.12.2019), 70 out of 215 females with H7_RETARTOCCTRANS died.

Males

Parameter	HR [95% CI]	p-value
H7_RETARTOCCTRANS	1.48 [1.11, 1.98]	0.008
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 228 males with H7_RETARTOCCTRANS died.

Mortality risk

Mortality risk for people of age

years, who have H7_RETARTOCCTRANS.

N-year risk	Females	Males
1	0.125%	0.28%
5	0.736%	1.675%
10	1.684%	4.116%
15	3.186%	7.73%
20	5.643%	12.837%

Relationships between endpoints

↥

Index endpoint: H7_RETARTOCCTRANS – Transient retinal artery occlusion

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Transient retinal artery occlusion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints